Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway

por Jin, Dan, Wu, Yan, Shao, Cuijie, Gao, Yong, Wang, Deqiang, Guo, Jiwei
Publicado 2018

Norcantharidin reverses cisplatin resistance and inhibits the epithelial mesenchymal transition of human non-small lung cancer cells by regulating the YAP pathway

por Jin, Dan, Wu, Yan, Shao, Cuijie, Gao, Yong, Wang, Deqiang, Guo, Jiwei
Publicado 2021

UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells

por Wu, Yan, Jin, Dan, Wang, Xiaohong, Du, Jing, Di, Weihua, An, Jiajia, Shao, Cuijie, Guo, Jiwei
Publicado 2019

Corrigendum to “UBE2C Induces Cisplatin Resistance via ZEB1/2-Dependent Upregulation of ABCG2 and ERCC1 in NSCLC Cells”

por Wu, Yan, Jin, Dan, Wang, Xiaohong, Du, Jing, Di, Weihua, An, Jiajia, Shao, Cuijie, Guo, Jiwei
Publicado 2020

Expression of microtubule-associated protein TPX2 in human gastric carcinoma and its prognostic significance

por Shao, Cuijie, Duan, Changsheng, Wang, Jiani, Luan, Shunlian, Gao, Yong, Jin, Dan, Wang, Deqiang, Li, Yuming, Xu, Lihua
Publicado 2016

The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC

por Jin, Dan, Guo, Jiwei, Wang, Deqiang, Wu, Yan, Wang, Xiaohong, Gao, Yong, Shao, Cuijie, Xu, Xin, Tan, Shuying
Publicado 2018

Retraction notice to ‘The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC’ [EBioMedicine 37 (2018) 188–204]

por Jin, Dan, Guo, Jiwei, Wang, Deqiang, Wu, Yan, Wang, Xiaohong, Gao, Yong, Shao, Cuijie, Xu, Xin, Tan, Shuying
Publicado 2021

DNMT3a methylation in neuropathic pain

por Shao, Cuijie, Gao, Yong, Jin, Dan, Xu, Xin, Tan, Shuying, Yu, Hui, Zhao, Qingxiang, Zhao, Li, Wang, Wansheng, Wang, Deqiang
Publicado 2017

Vibrio vulnificus necrotizing fasciitis with sepsis presenting with pain in the lower legs in winter: a case report

por Di, Weihua, Cui, Jing, Yu, Hui, Cui, Xiao, Sa, Huanlan, Fu, Zhong, Fu, Bingjin, Guan, Guofeng, Du, Rui, Shao, Cuijie, Gao, Yong
Publicado 2022